FDA Inspection 1016878 — Leica Biosystems Newcastle Ltd.
The FDA completed an inspection of Leica Biosystems Newcastle Ltd. on April 27, 2017 in Newcastle Upon Tyne. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 27, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Newcastle Upon Tyne (United Kingdom)